Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5.3Revenue $M5.8Net Margin (%)-430.5Altman Z-Score-24.7
Enterprise Value $M61.7EPS $-1.3Operating Margin %-642.4Piotroski F-Score1
P/E(ttm)--Beneish M-Score-5.1Pre-tax Margin (%)-430.5Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio1.0Cash flow > EarningsN
Price/Sales0.95-y EBITDA Growth Rate %--Current Ratio1.0Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-54.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M19.6ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ALXA

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ALXA is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ALXA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Grupo Ferrer Internacional, S.10% Owner 2014-10-27Sell0$0view
Kamemoto Edwin SSVP, Regulatory Affairs 2014-06-27Sell0$0view
RINGOLD GORDONDirector 2013-09-06Buy10,000$4.77-93.29view
KING THOMAS BRAXTONPres & CEO 2013-07-26Buy40,000$4.48-92.86view
KING THOMAS BRAXTONPres & CEO 2013-07-26Buy40,000$4.48-92.86view
LANSDOWNE PARTNERS AUSTRIA GMB10% Owner 2013-01-18Sell125,000$4.75-93.26view
LANSDOWNE PARTNERS AUSTRIA GMB10% Owner 2012-12-27Buy72,189$4.85-93.4view
Cassella James VEVP, R&D and CSO 2012-12-26Sell4,558$4.9-93.47view
Simms Michael JSVP, Operations & Manuf 2012-12-26Sell4,558$4.9-93.47view
LANSDOWNE PARTNERS AUSTRIA GMB10% Owner 2012-12-26Sell0$0-93.47view

Quarterly/Annual Reports about ALXA:

    News about ALXA:

    Articles On GuruFocus.com
    Wrong Marketing Lesson by Big Pharma May 03 2014 
    Weekly CEO Buys Highlight: RCL, PSXP, ALXA, PAY, HAFC Aug 05 2013 
    Royal Caribbean and Four Others Report $100 Thousand CEO Buys Jul 31 2013 
    President and CEO of Alexza Pharmaceuticals Inc. Thomas Braxton King Bought 40,000 Shares Jul 29 2013 
    Weekly CEO Buys Highlight: NYLD, ALXA, DOC, NTWK, SNV Jul 29 2013 
    Alexza Pharmaceuticals Inc. (ALXA) SVP, CFO & Sec August J Moretti sells 10,000 Shares May 07 2010 
    Alexza Pharmaceuticals Inc. (ALXA) SVP, CFO & Sec August J Moretti sells 14,000 Shares Dec 21 2009 
    Alexza Pharmaceuticals Inc. (ALXA) Pres & CEO Thomas Braxton King sells 45,000 Shares Dec 21 2009 
    Weekly CEO Buy Highlight: Winmark Corp, Alexza Pharmaceuticals Inc, Ladenburg Thalmann Financial Ser Oct 11 2009 

    More From Other Websites
    ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Jan 22 2016
    New Strong Buy Stocks for December 29th Dec 29 2015
    New Strong Buy Stocks for December 24th Dec 24 2015
    ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Dec 22 2015
    Alexza Pharmaceuticals Announces Receipt of NASDAQ Staff Determination; Alexza to Request Hearing... Dec 22 2015
    Why pSivida And Alexza Are Skyrocketing Dec 22 2015
    Alexza Pharmaceuticals Announces Interim Results from its Phase 2a Study of AZ-002 (Staccato®... Dec 21 2015
    ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 21 2015
    Alexza Pharmaceuticals Announces Interim Results from its Phase 2a Study of AZ-002 (Staccato®... Dec 21 2015
    New Strong Buy Stocks for December 18th Dec 18 2015
    New Strong Buy Stocks for December 11th Dec 11 2015
    ALEXZA PHARMACEUTICALS INC. Financials Dec 08 2015
    ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 05 2015
    Alexza Reports 2015 Third Quarter Financial Results Nov 05 2015
    ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Termination of a Material Definitive Agreement,... Oct 30 2015
    Alexza Pharmaceuticals Announces Intent to Reacquire U.S. Rights for ADASUVE® (loxapine) inhalation... Oct 30 2015
    Alexza to Report 2015 Third Quarter Financial Results on Thursday, November 5, 2015 Oct 15 2015
    ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Oct 14 2015
    Ferrer and Alexza Pharmaceuticals Provide Update on ADASUVE® European and Latin American Commercial... Oct 14 2015
    ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers Oct 13 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK